Within this context, galectin-3 emerges as a biomarker of interest, offering insights into the complex interactions between insulin resistance, chronic inflammation, and PCOS (Kruszewska et al., 2022). The gene discussed is LGALS3; the disease is polycystic ovary syndrome.